There is reason to be optimistic about Contrave after its progress vs competitors following launch just over one year ago and the backing of a dedicated salesforce of 900, through partner Takeda, selling into a massive potential market. Contrave was approved in the EU in March and recently signed a commercialization agreement with Kwang Dong in South Korea, communicating its ex-US strategy in its Q3 conference call whereby it plans a territory-by-territory approach. On our analysis, the stron
14 Dec 2015
Contrave - leading branded weight loss medicine
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Contrave - leading branded weight loss medicine
- Published:
14 Dec 2015 - Author:
-
Pages:
16
There is reason to be optimistic about Contrave after its progress vs competitors following launch just over one year ago and the backing of a dedicated salesforce of 900, through partner Takeda, selling into a massive potential market. Contrave was approved in the EU in March and recently signed a commercialization agreement with Kwang Dong in South Korea, communicating its ex-US strategy in its Q3 conference call whereby it plans a territory-by-territory approach. On our analysis, the stron